Latest News about AKRO
Recent news which mentions AKRO
   Nasdaq Tumbles 500 Points, Crude Oil Down Over 1%
   
  
  
  September 13, 2022
  From Benzinga
 
   Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
   
  
  
  September 13, 2022
  From Benzinga
 
   US Stocks Open Lower After Inflation Report, Dow Dips 700 Points
   
  
  
  September 13, 2022
  From Benzinga
 
   What Is Going on With NeuroBo (NRBO) Stock Today?
   
  
  
  September 13, 2022
  From InvestorPlace
 
   Why Is Akero Therapeutics (AKRO) Stock Up 120% Today?
   
  September 13, 2022
  Tickers 
   AKRO
  
  
  From InvestorPlace
 
   Peloton's Shake-Up Continues, but This Tiny Stock Doubled Early Tuesday
   
  
  
  September 13, 2022
  From Motley Fool
 
   12 Health Care Stocks Moving In Tuesday's Pre-Market Session
   
  
  
  September 13, 2022
  From Benzinga
 
   Akero Therapeutics Shares More Than Double After Lead NASH Candidate Aces Mid-Stage Study
   
  September 13, 2022
  Tickers 
   AKRO
  
  
  From Benzinga
 From InvestorPlace
 
   Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
   
  
  
  September 12, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   89 Biggest Movers From Friday
   
  
  
  June 21, 2022
  From Benzinga
 
   63 Biggest Movers From Yesterday
   
  
  
  June 17, 2022
  From Benzinga
 
   Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma
   
  
  
  June 16, 2022
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
   
  
  
  February 04, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
   
  
  
  October 20, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's After-Market Session
   
  
  
  October 19, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
   
  
  
  August 13, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
   
  
  
  August 11, 2021
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  August 10, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
   
  
  
  August 10, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
   
  
  
  August 06, 2021
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  August 05, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

